Xinjiang Medical University is the lead sponsor of 8 current clinical trials in our China register. 6 are recruiting patients now. The most common phase is Observational. The most-studied condition is Primary Aldosteronism.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Prognostic Model of Hypertension
NCT06160921 · ClinicalTrials.gov ↗ · Hypertension
|
Observational | Recruiting | 2020-01 | China |
|
Primary Aldosteronism: Superselective Embolization vs. Laparoscopic Endocrine Curative Therapy
NCT06513585 · ClinicalTrials.gov ↗ · Primary Aldosteronism, Suprarenalectomy, Super Selective Adrenal Artery Embolization
|
Not applicable | Recruiting | 2024-08 | China |
|
The Association Between Primary Aldosteronism and Cognitive Dysfunction
NCT07304674 · ClinicalTrials.gov ↗ · Primary Aldosteronism, Cognitive Dysfunction, Mild Cognitive Impairment (MCI)
|
Observational | Recruiting | 2025-12 | China |
|
Prognosis of Primary Aldosteronism: A Prospective Cohort Study
NCT07378176 · ClinicalTrials.gov ↗ · Primary Aldosteronism
|
Observational | Recruiting | 2026-01 | China |
|
Clinical Outcomes of Cardiovascular Disease
NCT06459934 · ClinicalTrials.gov ↗ · Cardiovascular Diseases, Heart Failure, Coronary Artery Disease
|
Observational | Recruiting | 2024-06 | China |
|
Super Selective Adrenal Artery Embolization for Primary Aldosteronism: a Prospective Cohort Study(SAAE-PA)
NCT06513676 · ClinicalTrials.gov ↗ · Primary Aldosteronism, Super Selective Adrenal Arterial Embolization
|
Observational | Recruiting | 2024-04 | China |
|
Precision Subtyping and Prognostic Study of Heart Failure Based on Multi-Omics Integration and Clinical Indicators: A Prospective Single-Center Cohort Study
NCT07355088 · ClinicalTrials.gov ↗ · Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF)
|
Observational | Not yet open | 2026-01 | China |
|
Structured Cardio-Oncology Rehabilitation for Cardiovascular Outcomes in Cancer Survivors
NCT07622394 · ClinicalTrials.gov ↗ · Cancer Therapy-Related Cardiac Dysfunction, Cardio-oncology, Cancer Survivorship
|
Not applicable | Not yet open | 2026-09 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 8 | 6 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Qifu Li | 5 |
| Chongqing Medical University | 3 |
| Third Military Medical University | 2 |
Sponsors with the most current trials registered for this condition.
Xinjiang Medical University is the lead sponsor of 8 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 6 of its 8 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.